Zai Lab Limited

About Zai Lab Limited

Zai Lab is a global biopharmaceutical company based in China and the U.S., focused on driving healthcare innovation by developing and commercializing transformative medicines for oncology, immunology, neuroscience, and infectious diseases. Their mission is to leverage China-based competencies to impact human health worldwide.

Products & Services

TIVDAK®:A treatment for patients with recurrent or metastatic cervical cancer, recently approved in Hong Kong.

Tumor Treating Fields:An innovative medical device designated for patients with pancreatic cancer by the China National Medical Products Administration.

Pipeline Products:A range of products under research and development, details available on their pipeline page.

Specialties

Oncology Immunology Neuroscience Infectious Diseases Research and Development Commercialization Manufacturing Clinical Trials

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering of American Depositary Shares (ADSs) T: - FT: Public Offering of American Depositary Shares (ADSs)	A: 230000000 MR: - FA: approximately $230 million FAN: 230000000	D: 2024-11-18 FD: 2024-11-18	3 investors
2	RT: Public Offering of American Depositary Shares T: - FT: Public Offering of American Depositary Shares	A: 200000000 MR: - FA: $200 million FAN: 200000000	D: 2024-11-14 FD: 2024-11-14	3 investors

Public Offering of American Depositary Shares (ADSs) Latest

2024-11-18

$230.0M

3 investors (Pro only)

Public Offering of American Depositary Shares 2024-11-14

$200.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Samantha Du, Ph.D.

Founder, Chairperson and Chief Executive Officer

R

Rafael G. Amado

President, Head of Global Research and Development

P

Prista Charuworn, M.D.

Vice President, Global Clinical Development, Neuroscience & Immunology (NSI)

Y

Yajing Chen, Ph.D.

Chief Financial Officer

C

Christine Chiou

Senior Vice President, Head of Investor Relations

F

F. Ty Edmondson

Chief Legal Officer and Corporate Secretary

View 38 more team members with Pro

Unlock Full Team Directory

Recent News

Zai Lab Limited Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised